Insider Transactions in Q3 2023 at Acumen Pharmaceuticals, Inc. (ABOS)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2023
|
Jeffrey L. Ives Director |
SELL
Open market or private sale
|
Direct |
41,949
-100.0%
|
$251,694
$6.57 P/Share
|
|
Aug 17
2023
|
Jeffrey L. Ives Director |
BUY
Exercise of conversion of derivative security
|
Direct |
41,949
+50.0%
|
$0
$0.96 P/Share
|
|
Jul 21
2023
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
5,161,290
+28.35%
|
$36,129,030
$7.75 P/Share
|